Myocardial perfusion scintigraphy in the diagnosis and prognostic assessment of coronary artery disease: SPET and PET;Koroner arter hastaliǧi tanisi ve prognoz belirlemede miyokard perfüzyon sintigrafisi: SPET ve PET

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue SUPPL. 1, 2008, Pages 5-11

  Ünlü, Mustafa ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Myocardial perfusion; PET; PET CT; SPET; SPET CT

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE WALL MOTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MYOCARDIAL PERFUSION SCINTISCANNING; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY ARTERY DISEASE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 48249104308     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Lebowitz E, Greene MW, Fairchild R, Bradley-Moore PR, Atkins HL, Ansari AN, et al. Thallium -201 for medical use. I. J Nucl Med 1975; 16: 151-5.
2. Ünlü M. Nükleer kardiyoloji görüntüleme teknikleri. Gazi Medical Journal (Gazi Tip Dergisi) 2006; 17: 23-33.
3. Frost and Sullivan Report. US Radiopharmaceutical Agents Markets. 3 June 2008. Available at URL: www.frost.com.
4. Administration of Radioactive Substance Advisory Committee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Didcot, UK: ARSAC Support Unit, National Radiological Protection Board, 1998.
5. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998; 280: 913-20.
6. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993; 22: 1455-64.
7. Kiat H, Van Train KF, Maddahi J, Corbett JR, Nichols K, McGhie AI, et al. Development and prospective application of quantitative 2-day stress-rest Tc-99m methoxy-isobutyl-isonitrile SPECT for the diagnosis of coronary artery disease. Am Heart J 1990; 120: 1255-66.
8. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69-77.
9. Kapur A, Latus KA, Davies G, Dhawan RT, Eastick S, Jarritt PH, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med Mol Imaging 2002; 29: 1608-16.
10. Turgut B, Ünlü M, Çengel A. Dobutamine stress tetrofosmin SPECT; evaluation of short rest-stress protocol and head to head comparison with MIBI in detection of coronary artery disease. Ann Nucl Mod 2005; 19: 115-22.
11. Thomas GS, Miyamoto MI, Morello AP 3rd, Majmundar H, Thomas JJ, Sampson CH, et al. Technetium-99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) Study. J Am Coll Cardiol 2004; 43: 213-23.
12. Lette J, Lapointe J, Waters D, Cerino M, Picard M, Gagnon A. Transient left ventricular cavitary dilation during dipyridamole- thallium imaging as an indicator of severe coronary artery disease. Am J Cardiol 1990; 66: 1163-70.
13. Schulman DS, Lazar JM, Ziady G, Grandis DJ, Flores AR, Orie JE. Right ventricular thallium-201 kinetics in pulmonary hypertension: relation to right ventricular size and function. J Nucl Med 1993; 34: 1695-700.
14. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-43.
15. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. American College of Cardiology; American Heart Association; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003; 42: 1318-33.
16. Gibbons IRS. American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines. J Nucl Cardiol 1996; 3: 436-42.
17. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Mod 2001; 42: 831-7.
18. Cerqueira MD. Diagnostic testing strategies for coronary artery disease: special issues related to gender. Am J Cardiol 1995,75: 52D-60D.
19. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999; 138: 1025-32.
20. Steingart RM, Hodnett P, Musso J, Feuerman M. Exercise myocardial perfusion imaging in elderly patients. J Nucl Cardiol 2002; 9: 573-80.
21. Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis. J Am Soc Nephrol 2003; 14: 431-9.
22. Eichstadt HW, Eskotter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol 1995; 76: 122A-125A.
23. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984; 310: 819-24.
24. 99mTc-MIBI SPECT. Nucl Med Commun 2004; 25: 479-86.
25. Kim DW, Park SA, Kim CG, Lee C, Oh SK, Jeong JW. Reversible defects on myocardial imaging early after stent implantation: a predictor of late restenosis. Int J Cardiovasc Imaging 2008; 24: 503-7.
26. Hachamovitch R, Di Carli MF. Methods and limitations of assessing new noninvasive tests. Circulation 2008; 117: 2684-90.
27. Heller GV, Bateman TM, Johnson LL, Cullom SJ, Case JA, Galt JR, et al. Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging. J Nucl Cardiol 2004; 11: 273-81.
28. Ünlü M. Positron emisyon tomografisi ve kardiyolojide kullanimi. Türk Kardiyoloji Seminerleri 2006; 2: 237-47.
29. Ter-Pogossian MM. Instrumentation for cardiac PET. In: Bergmann SR, Sobel BE, editors. Positron mission Tomography of the Heart. New York, NY: Futura Publishing Company Inc; 1992. p. 1-13.
30. Maisey MN, Wahl RL, Barrington SF. Atlas of Clinical Positron Emission Tomography. New York, NY: Oxford University Press Inc.; 1999.
31. Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006; 13: 24-33.
32. Husmann L, Wiegand M, Valenta I, Gaemperli O, Schepis T, Siegrist PT, et al. Diagnostic accuracy of myocardial perfusion imaging with SPECT and PET: a comparison with coronary angiography. Int J Cardiovasc Imaging 2008; 24: 511-8.
33. Camici PG, Gropler RJ, Jones T, L'Abbate A, Maseri A, Melin JA, et al. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac disease. European Heart Journal 1996; 17: 25-34.
34. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, et al. Assessment of coronary artery disease severity by positron emission tomography: Comparison with quantitative angiography in 193 patients Circulation. 1989; 79: 825-35.
35. Machac J. Cardiac positron emission tomography imaging. Semin Nucl Med 2005; 35: 17-36.
36. Knaapen P, Lubberink M. Cardiac positron emission tomography: Myocardial perfusion and metabolism in clinical practice. Clin Res Cardiol 2008 Apr 23. [Epub ahead of print].
37. Rosen SD, Uren NG, Kaski JC, Tousoulis D, Davies GJ, Camici PG. Coronary vasodilator reserve pain perception and sex in patients with syndrome X. Circulation 1994; 90: 50-60.
38. Gistri R, Ebert AG, Palombo C, Marabotti C, Choudhury L, Camici PG. Effect of blood pressure lowering on coronary vasodilator reserve in arterial hypertension. Cardiovasc Drugs Ther 1994; 8: 169-71.
39. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using PET. Circulation 1994; 90: 808-17.
40. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996; 94: 3232-8.
41. Dayanikli F, Stevens M, Pek S, Corbett J, Schweiger M. Reduced coronary flow reserve in insulin dependent diabetics demonstrated by dynamic N-13 ammonia PET. Proceedings of the 41st Annual Meeting; 2004 June 5-8; Orlando, Florida, USA. J Nuc Med 1994; 5 35: 4P (Abstract).
42. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Woo-Soo S, Nishikawa J, et al. Hyperglycemia rather than insulin resistance is related to coronary flow reserve in NIDDM. Diabetes 1998; 47: 119-24.
43. Sdringola S, Gould KL, Zamarka GL, McLain R and Garner J. A 6-month randomized, double-blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by PET in coronary artery disease. Am Heart J 2008: 155; 245-53.
44. Zhao XM, Delbeke D, Sandler MP, Yeoh TK, Votaw JR, Frist WH. Nitrogen-13-ammonia and PET to detect allograft coronary artery disease after heart transplantation: comparison with coronary angiography. J Nuc Med 1995; 36: 982-7.
45. Momose M, Schwaiger M. The role of PET in nuclear cardiology, Nuclear Medicine Annual 2002: 123-47.
46. 18F-labelled myocardial perfusion tracer. J Nucl Med 2008; 49: 630-6.
47. Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart 2008; 94: 360-7.
48. Nikol ED, Stirrup J, Reyes E, Roughton M, Padley SP, Rubens MB, et al. Sixty four slice computed tomography coronary angiography compared with myocardial perfusion scintigraphy for the diagnosis of functionally significant coronary stenoses in patients with low to intermediate likelihood of coronary artery disease. J Nucl Cardiol 2008; 15: 311-8.
49. Braess H, Dilsizian V. PET and CT in cardiac imaging. In: Dilsizian V, Pohost GM, editors. Cardiac CT, PET and MR. Malden, Massachusets, USA: Blackwell Publishing; 2006. p.221-37.